Why is FDA approval not enough to avoid customs issues for import shipments?
FDA compliance alone may not safeguard shipments from customs issues because customs jurisdiction covers everything crossing the border, including technical requirements unrelated to FDA standards. Even if a shipment fully complies with FDA or other regulatory bodies like USDA or EPA, it might face customs enforcement due to jurisdictional differences, increased enforcement authority, or technicalities specific to customs.
What were the inter-agency conflicts before NAFTA, and how have they evolved?
Before NAFTA, there were fewer inter-agency conflicts because many products were made domestically, reducing customs issues. Post-NAFTA, the increase in imports necessitated more collaboration between agencies. Initially, there was little coordination, leading to unresolved cases. Over time, particularly by the late 1990s, FDA and customs improved cooperation, exemplified by co-housing in Miami, which streamlined processes and reduced conflicts.
What are the biggest differences between FDA and CBP evaluations of imported products?
Customs focuses on border control, handling imported goods primarily at entry points, while FDA has different mandates for domestic and import regulation. Customs deals with goods crossing into domestic commerce, whereas FDA’s domestic and import divisions can operate separately. Changes post-9/11 led to more integration, but historical separation still affects operational perspectives, with USDA’s import inspectors even integrated into Homeland Security.
Can a shipment meet FDA requirements but still face customs problems?
Yes, a shipment can meet FDA requirements but face customs issues due to factors like tariffs, country of origin, valuation, and admissibility. Customs primarily focuses on classification, valuation, and origin, which are critical for determining duties. Misalignments between FDA product codes and customs HTS codes or discrepancies in valuation and origin can lead to customs challenges.
Where do importers often get blindsided in handling FDA and customs compliance?
Importers often face issues when FDA and customs compliance are handled separately, especially in pharmaceuticals and medical devices. Large organizations with dedicated FDA compliance teams might overlook the integration necessary with trade compliance, leading to disconnects that can create border issues when logistics teams handle entry requirements without full regulatory context.
What happens when CBP uncovers issues beyond the original concern during import reviews?
If CBP discovers issues beyond the initial concern, such as incorrect facility information or counterfeit products, it can escalate to significant actions, including criminal investigations. An example is when customs identified counterfeit pharmaceutical ingredients leading to broader investigations. The consequences depend on the severity, ranging from administrative actions to criminal cases.
How should companies integrate FDA and CBP compliance strategies operationally?
Companies should integrate FDA and CBP compliance by aligning SOPs and purchase orders. Ensuring all FDA and customs requirements are evaluated at the purchase order stage can prevent costly issues after shipment. Developing SOPs that incorporate both FDA and trade compliance helps create a unified operational approach, reducing the risk of compliance gaps and ensuring smooth import processes.
If you’re facing challenges with importing FDA-regulated products, we’re
here to help you navigate the process smoothly. Let us be your guide
through the complexities of trade tariffs, FDA compliance, and border issues. Visit us at FDAImports or contact us directly at contact @fdaimports.com for assistance.
This news update is provided for informational and educational purposes only and does not constitute legal advice and is not intended to form an attorney-client relationship. Please contact your regular FDAImports representative for additional information.
